790
A 56-year-old woman with scleroderma developed rapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis after 27 months of D-penicillamine therapy and a cumulative dose of 1,200 g.
 A 56-year-old woman with scleroderma: Subject; 56-year-old: Subject.Age; woman: Subject.Gender; rapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis: Effect; 27 months of D-penicillamine therapy and a cumulative dose of 1,200 g.: Treatment; scleroderma: Treatment.Disorder; 27 months: Treatment.Time_elapsed; D-penicillamine: Treatment.Drug; 1,200 g.: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A 56-year-old woman with scleroderma: Subject; 56-year-old: Subject.Age; woman: Subject.Gender; rapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis: Effect; 27 months of D-penicillamine therapy and a cumulative dose of 1,200 g.: Treatment; scleroderma: Treatment.Disorder; 27 months: Treatment.Time_elapsed; D-penicillamine: Treatment.Drug; 1,200 g.: Treatment.Dosage